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Background: People living with chronic disease currently account for the majority of the total healthcare costs. The
Central Denmark Region implemented a disease management programme (DMP) for chronic obstructive
pulmonary disease (COPD) in 2008. This presented an opportunity to examine the effect of an evidence-based,
planned and proactive implementation of a DMP compared to the usual implementation strategy.
Methods: We performed a block- and cluster-randomised controlled trial with two groups and an extra external
control group. The primary outcome was patients’ assessment of their care after using an active implementation
model for a DMP for COPD measured with the Patient-Assessment-of-Chronic-Illness-Care (PACIC) instrument. At
baseline, questionnaires were sent to 2,895 patients identified by an algorithm based on health registry data on
lung-related contacts to the healthcare system. Patients were asked to confirm or refute their diagnosis of COPD. Of
those who responded, 1,445 (72.8%) confirmed their diagnosis. PACIC data were collected at baseline and at a
12-month follow-up for 744 (51.1%) patients.
Results: Comparing the three groups after the implementation of the DMP, we found a statistically significantly
higher change in the PACIC score in the intervention group than in the control groups. No statistically significant
differences were found between the control and the external control groups in any of the dimensions.
Conclusions: Reinforcing the role of general practice as coordinator for care-and self-management-support with an
active implementation of a DMP for COPD made patients score higher on the PACIC instrument, which indicates a
better experience of the received healthcare.
Trial registration: NCT01228708.
Keywords: PACIC, Implementation, Disease management programme, Patient evaluation, COPD,
Chronic care model, RCTBackground
Shared decision-making in healthcare is becoming ever
more important. Patients want healthcare professionals
to include them in the decisions about their own health,
and they want to be involved in the management of their
own lives and diseases [1].
The number of patients with chronic disease is growing
as a result of inappropriate lifestyle, growing diagnostic* Correspondence: m.smidth@alm.au.dk
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reproduction in any medium, provided the oractivity, improved treatment options and increased life-
expectancy [2]. Currently, about a quarter of the 5.6
million Danes [3] are living with one or more chronic
diseases, and thus live with multimorbidity.
Patients with multimorbidity often spend much time
and encounter many frustrations when they undergo
specialised treatment as high-quality multidisciplinary
care is often characterized by lack of communication
and coordination between health professionals. Patients
experience inadequate continuity of care and they face
problems in accessing the health professionals they trust
[4-6]. Health professionals often consider encounters
with patients with multimorbidity demanding and theyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fessions [7]. The recent rapid growth in technology and
specialised treatment makes it feasible to centralise the
settings for specialised treatment. Unfortunately, specia-
lised treatment also paves the way for “silo thinking”
[8-10], and it is vital that care is tailored to the patients’
needs and that treatment is professional, effective and
non-fragmented [11]. People living with chronic diseases
currently account for 70-80% of the total healthcare costs
[12] and they are more frequently hospitalised than other
patients, which is costly and may hamper patient-centred
care. A framework for the concerted effort for the care for
people living with multimorbidity is needed to give these
patients’ an experience of a healthcare system that cooper-
ates to provide the best possible care.
One such strategy is the Chronic Care Model (CCM),
which has been successfully implemented in full or partly
in different healthcare settings [13,14]. The CCM supports
the provision of high-quality care where emphasis is
placed on the continuity of care in a strong primary care
sector [15] to ensure that patients are given the right care
at the right place at the right time and with optimised
use of resources [16]; such care should, moreover, be
evidence-based, planned and proactive [13].
It becomes important to ensure and support the im-
plementation of such care. This was underpinned in a
meta-analysis by Weingarten et al. who concluded that
the studied interventions for disease management prog-
rammes (DMPs) improved provider adherence and dis-
ease control and asked for future studies to directly
compare different types of interventions and models for
interventions [17]. Patient Assessment of Chronic Illness
Care (PACIC) is a patient evaluation tool developed to
measures specific actions or qualities of care which pa-
tients report that they have experienced in the delivery
system [18,19]. Glasgow et al. showed that greater exer-
cise adherence and higher PACIC score [19] were linked
for patients with diabetes and a cross-sectional study
from the North American insurance company Kaiser
Permanente where the CCM is fully implemented con-
cluded that PACIC could be used as a tool for health
systems to improve care for chronic diseases [20].
Denmark (3.02 mill citizens who are 35 years old or
older) is organised into five regions and 98 municipalities.
Responsibility for rehabilitation and preventive services lie
with the municipalities, and responsibility for the running
of the hospitals and for the provision of service from gen-
eral practice lies mainly with the regions [21]. Some of the
key elements in the CCM model have come to Denmark
in the sense that it has become mandatory to jointly plan
care in cooperation between the regions and the munici-
palities healthcare [15,22].
Chronic obstructive pulmonary disease (COPD) is an im-
portant chronic disease. Moreover, it is an under-diagnosed,irreversible and potentially life-threatening condition
where secondary prevention, treatment and rehabilitation
can help control the symptoms, increase the patient’s
quality of life and delay disease progression [23]. Newly
published results indicate that 14.3% of those who are
35 years or older have COPD [24]; and only approx. 28%
of these have been diagnosed [25].
A DMP for COPD was implemented in 2008 in the
Central Denmark Region (720,000 citizens aged 35 years
old or older) based on the CCM [23]. The programme uses
evidence-based clinical and organisational recommenda-
tions and is a manual on treatment, task distribution, com-
munication and coordination between stakeholders [12],
which has been shown to improve care for chronic condi-
tions [26]. The Central Denmark Region adopted the DMP
as standard care for patients with COPD.
To be able to support the patients in assuming an ac-
tive role in the management of their own illness, we
need research-based information, and a recently pub-
lished cross-sectional study from the Netherlands
showed that patients with COPD became more satisfied
with their care when a DMP had been implemented
[27]. Therefore, we developed an active implementation
model to test the active implementation compared to
the usual implementation of DMPs [28].
The aim of this paper is to present the effect of the
previously developed active implementation model for a
DMP for COPD on patients’ assessment of their care.
Methods
Study design
The study was a prospective, multicentre, block- and
cluster-randomised controlled trial with intervention and
control groups and an additional external control group to
enable estimates of the extent of spillover effect of the
intervention on the local control group [29,30]. The inter-
vention group consisted of patients from a randomly se-
lected half of the general practices in Ringkoebing-Skjern
municipality in the Central Denmark Region. Patients
from the other half of the practices formed the control
group. Patients in a comparable neighbouring municipality
all formed the external control group.
A validated COPD algorithm [31] was used to identify
the patients who were sent the baseline questionnaire at
the start of the intervention. A year later responders to
the baseline questionnaire who had confirmed their
COPD diagnosis were sent a follow-up questionnaire.
Both questionnaires included the PACIC instrument (see
Figure 1).
The primary outcome was the patients’ assessment of
the care received after implementation of the DMP for
COPD based on the CCM [23]. Patients’ assessments
were measured with the PACIC instrument [18], which
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Figure 1 Flowchart. Flowchart for inclusion of patients who scored at least 50% of the PACIC instrument in both the baseline and in the follow-up
questionnaire a year after the active implementation of a disease management programme for COPD.
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tients as far as the elements of the CCM were
concerned; i.e. the community, the healthcare system,
self-management support, delivery system design, deci-
sion support and clinical information systems. The
instrument has been translated and validated within the
Danish healthcare system [32].Participants
The patient population comprised patients aged 35 years
or older from the two municipalities; the patients had to
be registered with a GP practice in their residing munici-
pality and identified by the COPD algorithm [31] - where
patients were identified from administrative data which in-
dicated whether they had been hospitalised at least oncewith a lung-related diagnosis during the past five years
and/or had redeemed a prescription for lung medication
at least twice during the past year and/or had had two spi-
rometries performed at different days during the past year.
Furthermore, the patients were the responders to the
baseline questionnaire who had confirmed their COPD
diagnosis and answered at least 50% of the questions in
the PACIC instrument in both questionnaires. The patient
population belonged to the group to which their respect-
ive GP practices belonged.
The letter of invitation informed the patients about
the consequences of their participation and their pos-
sibility to withdraw at any time without any con-
sequences for their further treatment within the
healthcare system. It was therefore considered equiva-
lent to informed consent to participate in delivering
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the questionnaire.Setting
In Denmark, healthcare is free at the point of care and is
tax-financed. The approx. 3,600 Danish GPs have an
average of 1,600 patients on their list as approx. 99% of
the population is registered with a GP. The GPs are in-
dependent contractors with the region and remunerated
on a combination of fee-for-service and capitation basis
(75/25). GPs act as gatekeepers, and the patients on the
list must consult their GP in case of need for medical
advice except for emergency room services and for some
of the health-related services offered by the municipality.
Ringkoebing-Skjern municipality had approx. 58,000 in-
habitants of whom approx. 35,000 were aged 35 or above,
and the municipality had 38 GPs organised into 15 prac-
tices. The neighbouring municipality (Ikast-Brande) had
close to 40,000 inhabitants of whom approx. 24,000 were
aged 35 or above, and this municipality had 25 GPs
organised into 10 practices. All practices had staff that
conducted parts of or the entire consultation on their
own. The staff was employed by the GPs and was edu-
cated as nurses, laboratory technicians or secretaries.Intervention
The intervention practices undertook an active, struc-
tured implementation of a DMP for COPD.
The DMP from the Central Denmark Region [23] was
based on the GOLD Guidelines [12] and the clinical guide-
line from The Danish Society for General Practice [33]. It
uses evidence-based clinical and organisational recommen-
dations and is a manual on treatment, task distribution,
communication and coordination between stakeholders.
The programme includes i.a. smoking cessation, yearly
follow-up, flu and bronchitis vaccination, advice on
comorbidities, diet, exercise and end-of-life care.
The intervention is depicted in the Additional file 1; we
have described the development of the intervention in de-
tail elsewhere [28]. The intervention comprised compo-
nents from the main areas of the CCM - Policies and
Resources, Self-Management Support, Delivery System
Design, Organisation of Healthcare and Clinical Informa-
tion System [34]. To stimulate the process, we asked a
local, esteemed opinion leader to introduce and support
the intervention [35] both to GPs and to the municipality.
The intervention practices were invited to participate
in four two-and-a-half-hour sessions. The Breakthrough
Series [36] was used as a framework for the implemen-
tation of planned and targeted changes. All meetings
were chaired by experts and experienced facilitators,
who were all clinically educated and experienced in
aiding change in practice. One facilitator (MS) visitedeach practice to explore and/or address challenges en-
countered in pursuing their goals.
We negotiated our implementation strategy with the
municipality, which took active ownership by increasing
the number of free COPD courses and smoking cessa-
tion courses. The region agreed on providing a special
reimbursement to GPs for joint home visits together
with the community nurse to newly discharged COPD
patients [37].
Targeted self-management support for patients to cope
with exacerbations of the disease was an integral part of
our strategy, and we developed an action card with ad-
vice to patients on management of sputum and exacer-
bations. The action card was based on the research by
Robert Stockley [38].
To provide family, friends and the patients themselves
with more knowledge to improve their ability to cope
with their disease, we designed a website with informa-
tion about COPD including contact details to the muni-
cipality, patient support groups and the involved GPs.
The standard implementation of the DMP from the
Central Denmark Region went ahead and thus also cov-
ered all the groups in our study.
Randomisation and sample size
Randomisation and allocation concealment
An independent researcher drew slips that were matched
to an electronic record with all GP practices in the
Ringkoebing-Skjern municipality. The allocation of both
GPs and patients was open and known to GPs and re-
searchers for the intervention and the control groups.
The patients were not directly informed that their GP
practice participated in the study. They simply received
the questionnaires with a flyer, and posters were
exhibited in the waiting area in the practice. The exter-
nal control group was only known to the researchers.
The practices were block-randomised using three blocks
where the first block was solo-practices with two prac-
tices randomly allocated to the intervention group and
three to the control group. The second block was prac-
tices with two GPs: two practices were in the interven-
tion group and three in the control group. The third
block was practices with three or more GPs: there were
three practices in both the intervention and the control
group. There were two solo-practices, three practices
with two GPs and four with three or more GPs in the
external control group.
Out of the nine invited intervention practices, seven
accepted the invitation to participate. One practice with
three GPs was allocated to the intervention group as one
of the GPs was partly involved in the overall planning of
the study. The two practices that declined the invitation
were allocated to the control group as we wanted to
examine the effectiveness of the intervention. In total,
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control group and 25 in the external control group.Sample size
The sample size calculations were based on the primary
outcome for the expected changes and α = 0.05, β = 0.1,
sampling 1:1 and a minimal, relevant difference of 10%.
Approx. 10% of the patients with a chronic disease
attended a yearly follow-up consultation; and to ensure
statistically power for a change to 20%, we needed to in-
clude 360 patients in each of the groups in the randomised
controlled trial. For a minimal relevant difference of 10%
from 50% to 60%, 1,400 patients needed to be included.Patients
The COPD algorithm [31] identified 3,021 patients for in-
clusion in the study. Of those, 2,895 were sent a baseline
questionnaire (see Figure 1). Of the 1,445 patients (72.8%
of the responders to the baseline questionnaire) who con-
firmed their diagnosis, 1,383 (69.7% of the baseline re-
sponders) were sent a follow-up questionnaire 12 months
later. There were 228 (16.5%) non-responders to the
follow-up questionnaire. PACIC scores were collected
from the 744 (53.8%) patients who answered at least 50%
of the PACIC questions in both the baseline and the
follow-up questionnaire.Data collection
The PACIC tool includes 20 items in the following five
scales: Dimension 1: Patient Activation (items 1–3). Di-
mension 2: Delivery System Design/Decision Support
(items 4–6). Dimension 3: Goal Setting (items 7–11). Di-
mension 4: Problem-Solving/Contextual Counselling
(items 12–15). Dimension 5: Follow-up/Coordination
(items 16–20). Each scale is scored by averaging the
items completed within that scale, and an overall PACIC
score is scored by averaging scores across all 20 items.
At least 50% of the items have to be answered to calcu-
late a score. The PACIC was scored by summing partici-
pants’ responses across all 20 items. Scores on the
PACIC range from 1 to 5 with higher scores indicating a
patient’s perception of greater involvement in self-
management and receipt of chronic care counselling in
line with proactive care provided in line with the CCM.
In their paper on the process of translating and valid-
ating the PACIC into Danish, Maindal et al. found that
it had good face validity and the internal validation en-
dorsed the five proposed scales [32]. Scores were col-
lected from the patients who had answered at least 50%
of all the subscales in the PACIC instrument both at
baseline and at follow-up.Analyses
To measure the effectiveness of the implementation, we
used as-treated analysis, i.e. the practices actually partici-
pating in the intervention formed the intervention
group. We also performed an intension-to-treat analysis
as a sensibility analysis (i.e. the two practices that re-
fused to be in the intervention group were analysed as
intervention practices).
We compared the difference between the mean differ-
ence in change in scores for the corresponding pairwise
comparisons between intervention, control and external
control groups to eliminate any variation at baseline.
Two-sample t-test was used to test the differences be-
cause the differences were normally distributed.
At baseline, responders and non-responders were
compared in terms of gender and age. Responders with
full follow-up and non-responders to the follow-up
questionnaire were compared in terms of age and base-
line PACIC scores for each scale and the total PACIC
score using two-sample t-test. The distribution of gender
was tested by Pearson's chi-square test.
We applied a significance level of 5%; and in connec-
tion with testing of the scales of PACIC, a Bonferroni
level of 1% was considered to account for multiple test-
ing. Analyses were performed using STATA version 11.0.
(StataCorp, College Station, Texas). The trial followed
the consolidated standards of reporting trials guideline
extended for cluster-randomised controlled trials [34].Ethics
The study was recommended by the Multi Practice Com-
mittee of the Danish Society of General Practitioners and
the Association of Danish General Practitioners (MPU
17–2009) and approved by the Danish Data Protection
Agency (J.nr. 2008-41-2855), the Danish National Board
of Health (J. NR.: 7-604-04-2/71/EHE); and the RCT is
indexed at http://clinicaltrials.gov/show/NCT01228708.
According to the Scientific Ethics Committee for the
Region of Central Jutland, the Biomedical Research Ethic
Committee System Act did not apply to this project.Results
Baseline characteristics
Patients
No gender differences between responders and non-
responders were observed in the intervention group or in
the external control group. The control group counted
more men than women (59.7% men (p = 0.007)). No statis-
tically significant age difference between responders and
non-responders was found in any of the groups. For the
full study population, the responders’ mean age was
67.1 years [95% CI: 66.4;67.9] vs. 66.6 years [95% CI:
65.7;67.6], (p = 0.418) for non-responders (see Table 1).
Table 1 Baseline data for patients as listed in the Danish health insurance service registry by 1 November 2008
Patients who confirmed that they had COPD
Intervention Control Ext. control Total
N (%) 424 (29.3) 451 (31.2) 570 (39.4) 1445 (100)
Men (%) 206 (48.3) 217 (48.1) 284 (49.8) 707 (48.9)
Female (%) 218 (51.7) 234 (51.9) 286 (50.2) 738 (51.1)
Mean age (min-max) 68.3 (35–91) 66.5 (35–95) 67.2 (36–95) 67.3 (35–95)
Patients who answered at least 50% of the PACIC questions in both questionnaires
Intervention Control Ext. control Total
n (%) 207 (27.8) 236 (31.7) 301(40.5) 744 (100)
Proportion of N (%) 48.8 52.3 52.8 51.5
Men (%) 106 (51.2) 126 (53.4) 143 (47.8) 375 (46.6)
Female (%) 101 (48.8) 110 (46.6) 158 (52.2) 369 (53.4)
Mean age (min-max) 68.7 (39–91) 65.8 (35–89) 67.2 (36–90) 67.1 (35–91)
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with follow-up and that of those with no follow-up was
only statistically significantly different in the control
group in regard to goal setting (dimension 3), where re-
sponders with follow-up had a baseline mean score of
1.79 [95% CI: 1.68;1.90] and non-responders one of 1.52
[95% CI:1.34;1.70], (p = 0.013).
Outcome
Table 2 shows the baseline scores, the follow-up scores
and the differences between the groups for PACIC. For
all three groups, the mean scores for each of the scales
and for the total PACIC score were all below 3, both at
baseline and at follow-up (max. score is 5). The scores
in the intervention group tended to be higher, though
not statistically significantly so, than in both control
groups at baseline (see Table 2).
In the intervention group, the total PACIC score rose
from 2.06 to 2.14 (difference = 0.08 [95% CI: 0.00;0.16]),
while a decrease of 0.05 [95% CI: -0.14;0.04] was seen in
the control group. The implied intervention effect was
0.12 [95% CI: 0.00;0.25], (p = 0.048). The effect of the ac-
tive implementation when comparing the intervention
group and the external control group was 0.14 [95% CI:
0.03;0.25], (p = 0.014).
Comparison of the intervention group and the control
group showed a change for the scales measuring delivery
system design and decision support (dimension 2): 0.19
[95% CI: 0.00;0.37], (p = 0.044) and for the scale of goal
setting (dimension 3): 0.20 [95% CI: 0.05;0.35], (p = 0.009).
No difference between the control and the external
control group was observed for any of the scales. The
only statistically significant difference between men and
women was seen in the control group’s goal setting scale
(dimension 3), where men scored 1.83 [95% CI: 1.69;1.97]
and women 1.60 [95% CI: 1.49;1.72], (p = 0.016).Although these results were just significant according
to the 1% Bonferroni level, together they point in the
same direction just like the sensitivity analysis, where
the intention-to-treat analysis showed approximately
the same patterns as the as-treated analysis. A statisti-
cally significant difference in change was observed be-
tween the intervention group and the control group on
the goal setting scale (dimension 3); the change in the
total PACIC score between these two groups was 0.09
[95% CI: -0.03;0.21], (p = 0.134). The overall total
PACIC score change between the intervention and the
external control group was 0.11 [95% CI: 0.01;0.22],
(p = 0.038) (data not shown but available).
Discussion
In this randomised trial, we found a statistically signifi-
cant change in the mean differences in the total PACIC
score between the intervention group and on the one
hand the control group and the external control group
on the other hand. The care received was thus given a
higher score by patients in the intervention practices
than by patients in the control groups.
The results show that the active intervention changed
the way patients evaluated their overall care in general
and patient activation, delivery system design and deci-
sion support and goal setting in particular. However,
our results also showed no noteworthy changes for the
two dimensions measuring problem-solving/contextual
counselling and follow-up/coordination of care. This
finding indicates that the implementation of the DMP
did not affect the way health professionals support pa-
tients in dealing with the challenges of living with
COPD and the way they interact with other healthcare
providers involved in the patient’s care. It is possible
that it is simply too demanding for Danish health pro-
fessionals to share care considerations both with other
Table 2 PACIC scores
N = 744 Intervention Control External control
N = 207 N = 236 N = 301
PACIC dimension 1 – Patient activation (203) (230) (298)
Baseline 2.39 [2.25;2.54] 2.31 [2.15;2.46] 2.27 [2.15;2.41]
Follow-up 2.48 [2.33;2.64] 2.22 [2.07;2.37] 2.11 [1.99;2.23]
Difference 0.09 [-0.06;0.23] -0.07 [-0.22;0.08] -0.16 [-0.28;-0.03]
Difference compared with Control 0.16 [0.05;0.37] p = 0.142 - -
Difference compared with External control 0.25 [0.05;0.44] p = 0.013 0.09 [-0.10;0.28] p = 0.363 -
PACIC dimension 2 – Delivery system design/decision support (206) (233) (299)
Baseline 2.78 [2.65;2.92] 2.76 [2.63;2.90] 2.67 [2.55;2.78]
Follow-up 2.86 [2.73;3.00] 2.63 [2.49;2.77] 2.53 [2.42;2.64]
Difference 0.07 [-0.05;0.19] -0.12 [-0.25;0.02] -0.13 [-0.24;-0.02]
Difference compared with Control 0.19 [0.00;0.37] p = 0.044 - -
Difference compared with External control 0.20 [0.04;0.37] p = 0.018 0.01 [-0.16;0.19] p = 0.868 -
PACIC dimension 3 – Goal setting (204) (234) (299)
Baseline 1.74 [1.62;1.89] 1.80 [1.69;1.92] 1.65 [1.55;1.75]
Follow-up 1.88 [1.76;2.00] 1.71 [1.60;1.81] 1.64 [1.55;1.73]
Difference 0.12 [0.01;0.23] -0.08 [-0.19;0.02] -0.01 [-0.09;0.08]
Difference compared with Control 0.20 [0.05;0.35] p = 0.009 - -
Difference compared with External control 0.12 [-0.01;0.26] p = 0.071 -0.08 [-0.21;0.07] p = 0.260 -
PACIC dimension 4 – Problem-solving/Contextual Counseling (204) (231) (296)
Baseline 2.26 [2.12;2.40] 2.22 [2.08;2.37] 2.05 [1.93;2.17]
Follow-up 2.33 [2.18;2.48] 2.13 [2.00;2.27] 2.00 [1.89;2.12]
Difference 0.06 [-0.07;0.18] -0.05 [-0.18;0.08] -0.06 [-0.16;0.05]
Difference compared with Control 0.11 [-0.08;0.29] p = 0.258 - -
Difference compared with External control 0.11 [-0.05;0.28] p = 0.172 0.01 [-0.16;0.17] p = 0.929 -
PACIC dimension 5 – Follow-up/Coordination (200) (223) (288)
Baseline 1.56 [1.45;1.66] 1.48 [1.40;1.56] 1.44 [1.36;1.51]
Follow-up 1.58 [1.48;1.67] 1.51 [1.42;1.60] 1.42 [1.35;1.49]
Difference 0.01[-0.08;0.11] 0.03 [-0.05;0.12] -0.05 [0.12;0.03]
Difference compared with Control -0.02 [-0.15;-0.11] p = 0.760 - -
Difference compared with External control 0.06 [-0.06;0.18] p = 0.343 0.08 [-0.04;0.20] p = 0.179 -
PACIC Total – The overall score (207) (236) (301)
Baseline 2.05 [1.95;2.15] 2.02 [1.92;2.13] 1.92 [1.83;2.01]
Follow-up 2.14 [2.03;2.24] 1.97 [1.86;2.07] 1.87 [1.78;1.95]
Difference 0.08 [0.00;0.16] -0.05 [-0.14;0.04] -0.06 [-0.13;0.01]
Difference compared with Control 0.12 [0.00;0.25] p = 0.048 - -
Difference compared with External control 0.14 [0.03;0.25] p = 0.014 0.01 [-0.10;0.13] p = 0.827 -
The mean PACIC scores for each dimension and the total score for each group recorded at baseline and at follow-up. The change in difference of means scores
when comparing the control and external control group, respectively, with the intervention group is shown together with a comparison of change in mean scores
between the control and external control groups.
The number of patients who have scored 50% of the dimension is shown for each group in brackets ().
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finding highlights a target area for future active imple-
mentation models designed to ensure further change in
the care for patients living with COPD.Comparison with other studies
In a study from the Department of Veterans Affairs in the
United States, patients evaluated their care higher if the
care they received emphasised self-management, and this
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disease [39]. In a Danish study where patients assessed the
care in general practice using the DANPEP (Danish pa-
tients evaluate practice) instrument [40], the patients were
more likely to recommend their GP if the care they
received was emphatic, patient-oriented, informative and
coordinated than if it was easily accessible [41]. In these
studies, the patients evaluated their care in one part of
the healthcare system only, i.e. general practice. Several
randomised controlled trials with complex interventions
are being planned in different countries in which the
PACIC will be used to measure the effect of the interven-
tions on patients’ assessment of their care from all sectors.
One such example is the study by van Lieshout et al. who
are planning to measure the effect of two strategies for
patients with chronic heart failure using the PACIC [42].
Other studies have used PACIC to illustrate how partici-
pation in a DMP affects patients’ evaluation of their care
compared to patients who are not in a programme. In one
such cluster-randomised study where the researchers ad-
ministered the PACIC instrument over the telephone
18 months after having implemented a “Guided Care”
programme for multi-morbid older persons, the patients
had twice as high odds for rating their chronic care highly
if they had received the programme than if they had not
[43]. The multi-morbid older persons scored higher on all
PACIC scales, even when they were not receiving the
“Guided Care”, than the intervention patients in our study
did after the implementation. The same did patients with
COPD in a Dutch study [27] which investigated whether
patients enrolled in DMPs perceived the quality of care to
be better than those who received the usual care. Com-
pared to these two studies, the intervention patients in
our study scored remarkably lower on the Follow-up/
Coordination and the Goal setting dimensions, which may
point in the direction where the active implementation
model would benefit from a stronger focus in the future.
Hence, no noteworthy change in these two dimensions
was observed in our study.
In a different Dutch study conducted to assess if the
care in primary care was congruent with the CCM, pa-
tients with cardio-vascular disease and patients with
COPD evaluated their care [44]. Again, their scores are
higher than the scores for the intervention patients in
the present study; and although the pattern for the
scores is similar, the greatest difference is for the Follow-
up/Coordination and the Goal setting dimensions.
Strengths and limitations
The strength of our study is its randomised design and
the inclusion of an external control group to assess the
extent of Hawthorne bias and any spill-over effect.
Hawthorne bias could arise if patients were happy that
“something” was happening with their care and did notknow what else the healthcare system could aspire to
provide. This potential bias and any spill-over effect
could explain why no statistically significant difference
between the intervention group and the control group
was found in the patient-activation scale, but the result
from the external group makes this less probable.
The Danish version of the PACIC instrument was
translated and validated in a population with diabetes
and it was culturally adapted [32]. We chose to use the
PACIC instrument among others because an Australian
study concluded that it was a feasible instrument for
comparing patients’ assessment of the quality of care in
those situations where they interact with the healthcare
system, especially where emphasis is given to self-
management [45]. Furthermore, Vrijhoef concluded that
the PACIC instrument is the most appropriate instru-
ment among the existing generic instruments that meas-
ure patients’ experience of their integrated care for
chronic conditions [46].
A weakness of the present intervention, one that is
present in most health services research, is that recruit-
ment of patients for the courses covered the whole of
Ringkoebing-Skjern municipality and not just the inter-
vention practices. This is one of the obvious drawbacks
of health services interventions and this bias would tend
to underestimate the actual effect of the intervention.
We chose to only analyse those 53.8% of responders to
the follow-up questionnaire who had answered at least
50% of all PACIC questions in both questionnaires. In no
way can we reject that these 53.8% of the patients is a se-
lected group who answered at least half instead of some or
no PACIC questions at all, and they may not be represen-
tative of the full population. We were interested in making
a comparison between groups, and the risk for selection
connected to randomisation group -“double skewed drop-
out” – is therefore considered to be minimal.
There were more men than women in the control
group. This could introduce a bias as they might value
specific parts of their care in other ways than women.
Another bias could be that responders with follow-up
scored higher than those without in the control group as
far as goal setting was concerned; however, a lower score
would only increase the size of the change; and since we
compare the mean of the change, the difference would
then become even more significant.
The trend towards higher baseline scores for the inter-
vention group could imply that intervention practices
already had increased their focus on the collaborative
care for the patients with COPD. To assess the effect of
the intervention, we used a difference-in-difference ap-
proach that captured the change in the mean of the dif-
ference between the baseline and the follow-up score
whereby we eliminated differences at baseline by focus-
ing only on the change between baseline and follow-up.
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with COPD as possible, we were only able to identify those
who had been in contact with the healthcare system where
lung-related complaints had caused the healthcare system
to take action. It would have been better if the Inter-
national Coding System for Primary Care (ICPC-coding)
had been implemented completely and validated in Danish
general practice, which would have made it possible to in-
clude also milder degrees of COPD. However, that was
not a possibility at the time of this study.
We chose to consider the two GP practices that de-
clined to participate in the intervention as part of the
control group because we wanted to examine the effect-
iveness of the active implementation and they would not
be among the practices receiving any of the elements.
These two practices were included in our sensibility ana-
lysis as intention-to-treat. The difference seen between
the intervention group and the control group in the as-
treated analysis and the absence of any difference in the
intention-to-treat analysis suggests that a possible spill-
over effect did not influence the patients’ evaluation.
We could have excluded the two practices that de-
clined invitation. However, if the two practices were just
two normal GP practices in Ringkoebing-Skjern, their
exclusion would have decreased the statistical precision
and this had weakened the conclusions of the ran-
domised study.
Conclusions
This study showed that patients gave a more positive
evaluation of the care they received for their COPD after
an active implementation of a DMP for COPD focusing on
the GP’s role as a coordinator of the care and on self-
management than after standard implementation of a
DMP for COPD. Thus, the present study supports the idea
of active implementation strategies when implementing
new healthcare programmes. The results of the PACIC as-
sessment can also guide us in the direction of where the
active implementation model could be improved, namely
in the areas of problem solving and follow-up.
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